NCT05141071View on ClinicalTrials.gov

Effect of Ivabradine on Microcirculation and Cardiac Output in Septic Shock Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

May 25, 2022

Study Completion Date

June 5, 2022

Conditions
Septic Shock
Interventions
DRUG

Ivabradine 5mg Tab

Ivabradine will be administrated enterally

DRUG

Placebo

50 ml of saline will be administrated enterally

Trial Locations (1)

11562

Kasr Alainy Hospital, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT05141071 - Effect of Ivabradine on Microcirculation and Cardiac Output in Septic Shock Patients | Biotech Hunter | Biotech Hunter